This month is the official start of spring. Flowers are beginning to bloom, birds are chirping and a shiny new flock of doctors and medical students are about to blossom into childhood cancer researchers. Yep, it’s that time – it’s time to award $2 million in Summer Fellow and Fellowship grants!
These grants encourage and support the newest generation of doctors and students in pursuing childhood cancer research, so they can move the field forward and save the lives of the next generation of kids.
February 4 is World Cancer Day. On this day, more than 700 kids will be diagnosed with cancer. But YOU can help. Here’s how …
When kids get cancer, a piece of their childhood is taken away. And even if they survive, their lives will never be the same.
But you can do something about it.
This World Cancer Day, let’s take childhood back from cancer.
Here are four easy ways you can help:
2017 was a big year, full of breakthroughs, incredible stories and some pretty amazing achievements in the childhood cancer world. Join us as we reflect on St. Baldrick’s top 10 highlights of the past year — and make sure you give yourself a pat on the back, because much of this was possible because of YOU!
Are you ready to take a trip down memory lane? Here we go …
1) Passage of the RACE Act
That’s right — it’s time to take the plunge and register for a St. Baldrick’s event!
Every 2 minutes, a child is diagnosed with cancer.
YOU can make a difference for these kids.
Be a part of the world’s largest volunteer-powered charity for childhood cancer research. Get involved with a St. Baldrick’s event today!
Usually, we pick one international winner of the Robert J. Arceci Innovation Award, but what happens when there are two equally deserving researchers with big ideas and big hearts for kids with cancer? Read on to find out!
After being nominated for the International Robert J. Arceci Innovation Award, (left) Dr. Franck Bourdeaut and (right) Dr. Jan-Henning Klusmann were both selected by a committee of experts and are being presented with the award today at the annual conference for the International Society of Paediatric Oncology.
Dr. Robert Arceci was a passionate innovator who dreamed big. He was a pioneer who knew that kids with cancer deserve better than what doctors can offer them and that breakthroughs are born from taking risks.
That’s why the international winner of the award established in his memory – the Robert J. Arceci Innovation Award – is given the resources and the freedom to follow their curiosity, pioneering spirit, and their passion for kids’ cancer research, wherever it leads.
Except this year, it’s winners of the Robert J. Arceci Innovation Award!
They say the early bird gets the worm, but at St. Baldrick’s, the early bird gets a cruise! That’s right – it’s time for the St. Baldrick’s Participant Sweepstakes, when participants who register and raise money early get a chance at the trip of a lifetime. Read on for tales from last year’s lucky shavee and the details on how YOU can be a winner.
Six-time shavee Jim and his family won big through the St. Baldrick’s Participant Sweepstakes — they won a weeklong Disney cruise! Here they are enjoying the beach at Castaway Cay, Disney’s private island in the Bahamas.
When Jim Varagona got an email saying he had won a free trip, he was skeptical. Did he get hacked? Was it a scam?
“I read the email and it looked legit, but you can’t be too sure when being told you’re a prize winner,” he said.
Then he listened to a voicemail he had just received. It was from the St. Baldrick’s Foundation. A six-time shavee and passionate fundraiser for kids’ cancer research, Jim had been randomly picked as the winner of the 2016 St. Baldrick’s Participant Sweepstakes.
Last week, in the pages of the medical journal Cancer Cell, St. Baldrick’s researchers announced a discovery that could radically transform treatment for kids with neuroblastoma – a new immunotherapy drug candidate that harnesses the immune system to fight cancer.
Neuroblastoma is a cancer that begins in the nerve tissue outside the brain, usually in a child’s abdomen. It strikes very young children, up to about age 7, and is the most common cancer diagnosed in infants. Only about 50% of patients survive the high-risk form of neuroblastoma.
All of this makes this new targeted immunotherapy for neuroblastoma especially good news, but it gets even better.
St. Baldrick’s supporters, this is a day to celebrate! You have helped make history. Today, the FDA approved the first gene therapy available in the United States. Called Kymriah, it’s an entirely new way of treating cancer and it’s saving lives.
This “living drug” is for patients with a type of acute lymphoblastic leukemia (ALL), a cancer of the blood and bone marrow and the most common form of childhood cancer. Scientists genetically modify a patient’s own immune cells in the lab, then infuse these new cells back into the patient’s body. These modified cells – called CAR T cells or chimeric antigen receptor T cells – then prompt the child’s own immune system to attack and kill leukemia cells.
As one of the most exciting projects supported by St. Baldrick’s – the SU2C-St. Baldrick’s Pediatric Cancer Dream Team – nears the end of its funding, a group of expert reviewers met at Stanford University on July 14th to evaluate its impact to date. To say they were impressed would be an understatement.
Members of the Dream Team gather at a meeting in July to discuss the impact of their research efforts.
The day began with a report from Dr. Stephan Grupp, director of the Cancer Immunotherapy Program at Children’s Hospital of Philadelphia.
He had flown to the Dream Team meeting straight from the Maryland headquarters of the Food and Drug Administration (FDA), where hundreds had packed a hearing room the day before. An FDA advisory panel was considering what could soon be the first gene therapy to be marketed in the United States, pioneered by Dr. Grupp and his colleagues.
When the school bell rang for summer break, what did you do? Swim like a fish? Swing as high as the stars? Swoon over your summer love? Press pause on reliving those childhood glory days for a second, because we’ve got great news. Together, we are helping kids with cancer get back to being kids — all that summer fun included. Say hello to our 2017 Summer Grants!
Dr. Hilary Marusak received a St. Baldrick’s Supportive Care Research grant for her work studying whether a martial arts therapy that focuses on meditation and breathing techniques can reduce pain — and pain’s negative long-term impact — in kids with cancer and survivors.
Today, St. Baldrick’s is proud to announce our latest round of grants — our 2017 Summer Grants, totaling $23.5 million.
« Newer PostsOlder Posts »